236 related articles for article (PubMed ID: 9923922)
1. Gallbladder adenomas have molecular abnormalities different from those present in gallbladder carcinomas.
Wistuba II; Miquel JF; Gazdar AF; Albores-Saavedra J
Hum Pathol; 1999 Jan; 30(1):21-5. PubMed ID: 9923922
[TBL] [Abstract][Full Text] [Related]
2. Genetic alterations in gallbladder adenoma, dysplasia and carcinoma.
Kim YT; Kim J; Jang YH; Lee WJ; Ryu JK; Park YK; Kim SW; Kim WH; Yoon YB; Kim CY
Cancer Lett; 2001 Aug; 169(1):59-68. PubMed ID: 11410326
[TBL] [Abstract][Full Text] [Related]
3. K-ras mutation and loss of heterozygosity of the adenomatous polyposis coli gene in patients with colorectal adenomas with in situ carcinoma.
Zauber NP; Sabbath-Solitare M; Marotta SP; Bishop DT
Cancer; 1999 Jul; 86(1):31-6. PubMed ID: 10391560
[TBL] [Abstract][Full Text] [Related]
4. Genetic abnormalities involved in the pathogenesis of gallbladder carcinoma.
Wistuba II; Albores-Saavedra J
J Hepatobiliary Pancreat Surg; 1999; 6(3):237-44. PubMed ID: 10526058
[TBL] [Abstract][Full Text] [Related]
5. Mutational analysis of BRAF in gallbladder carcinomas in association with K-ras and p53 mutations and microsatellite instability.
Saetta AA; Papanastasiou P; Michalopoulos NV; Gigelou F; Korkolopoulou P; Bei T; Patsouris E
Virchows Arch; 2004 Aug; 445(2):179-82. PubMed ID: 15221372
[TBL] [Abstract][Full Text] [Related]
6. Frequent p53 gene mutations in serrated adenomas of the colorectum.
Hiyama T; Yokozaki H; Shimamoto F; Haruma K; Yasui W; Kajiyama G; Tahara E
J Pathol; 1998 Oct; 186(2):131-9. PubMed ID: 9924427
[TBL] [Abstract][Full Text] [Related]
7. APC, K-ras codon 12 mutations and p53 gene expression in carcinoma and adenoma of the gall-bladder suggest two genetic pathways in gall-bladder carcinogenesis.
Itoi T; Watanabe H; Ajioka Y; Oohashi Y; Takel K; Nishikura K; Nakamura Y; Horil A; Saito T
Pathol Int; 1996 May; 46(5):333-40. PubMed ID: 8809879
[TBL] [Abstract][Full Text] [Related]
8. Mutations in the RAS/RAF/MAP kinase pathway commonly occur in gallbladder adenomas but are uncommon in gallbladder adenocarcinomas.
Pai RK; Mojtahed K; Pai RK
Appl Immunohistochem Mol Morphol; 2011 Mar; 19(2):133-40. PubMed ID: 21307665
[TBL] [Abstract][Full Text] [Related]
9. Losses of heterozygosity on chromosomes 17p and 9p/18q may play important roles in early and advanced phases of gallbladder carcinogenesis.
Hidaka E; Yanagisawa A; Sakai Y; Seki M; Kitagawa T; Setoguchi T; Kato Y
J Cancer Res Clin Oncol; 1999; 125(8-9):439-43. PubMed ID: 10480335
[TBL] [Abstract][Full Text] [Related]
10. Molecular changes in the Ki-ras and APC genes in colorectal adenomas and carcinomas arising in the same patient.
Zauber NP; Sabbath-Solitare M; Marotta SP; Zauber AG; Bishop DT
J Pathol; 2001 Mar; 193(3):303-9. PubMed ID: 11241408
[TBL] [Abstract][Full Text] [Related]
11. Ras gene point mutations in gallbladder lesions associated with anomalous connection of pancreatobiliary ducts.
Iwase T; Nakazawa S; Yamao K; Yoshino J; Inui K; Yamachika H; Kanemaki N; Fujimoto M; Okushima K; Miyoshi H; Taki N; Nakamura Y; Mizutani S; Horibe Y; Masui T; Tatematsu M
Hepatogastroenterology; 1997; 44(17):1457-62. PubMed ID: 9356872
[TBL] [Abstract][Full Text] [Related]
12. Allele-specific mutations involved in the pathogenesis of endemic gallbladder carcinoma in Chile.
Wistuba II; Sugio K; Hung J; Kishimoto Y; Virmani AK; Roa I; Albores-Saavedra J; Gazdar AF
Cancer Res; 1995 Jun; 55(12):2511-5. PubMed ID: 7780959
[TBL] [Abstract][Full Text] [Related]
13. Genetic alterations in sporadic and Crohn's-associated adenocarcinomas of the small intestine.
Rashid A; Hamilton SR
Gastroenterology; 1997 Jul; 113(1):127-35. PubMed ID: 9207270
[TBL] [Abstract][Full Text] [Related]
14. The sequential accumulation of genetic alterations characteristic of the colorectal adenoma-carcinoma sequence does not occur between gastric adenoma and adenocarcinoma.
Maesawa C; Tamura G; Suzuki Y; Ogasawara S; Sakata K; Kashiwaba M; Satodate R
J Pathol; 1995 Jul; 176(3):249-58. PubMed ID: 7674088
[TBL] [Abstract][Full Text] [Related]
15. Analysis of K-ras codon 12 mutations and p53 overexpression in colorectal nodule-aggregating tumors.
Kusaka T; Fukui H; Sano Y; Ueda Y; Chiba T; Fujimori T
J Gastroenterol Hepatol; 2000 Oct; 15(10):1151-7. PubMed ID: 11106095
[TBL] [Abstract][Full Text] [Related]
16. [K-ras gene mutation in gallbladder carcinoma].
Roa JC; Roa I; de Aretxabala X; Melo A; FarÃa G; Tapia O
Rev Med Chil; 2004 Aug; 132(8):955-60. PubMed ID: 15478297
[TBL] [Abstract][Full Text] [Related]
17. Genetic heterogeneity of the c-K-ras locus in colorectal adenomas but not in adenocarcinomas.
Shibata D; Schaeffer J; Li ZH; Capella G; Perucho M
J Natl Cancer Inst; 1993 Jul; 85(13):1058-63. PubMed ID: 8515492
[TBL] [Abstract][Full Text] [Related]
18. Using biopsy materials to detect mutations in gastrointestinal tumors.
Hosoi H; Hirosawa S; Yamamoto K; Ohkusa T; Aoki N
J Clin Gastroenterol; 1995 Jun; 20(4):272-6. PubMed ID: 7665812
[TBL] [Abstract][Full Text] [Related]
19. K-ras and p53 mutations in stage I gallbladder carcinoma with an anomalous junction of the pancreaticobiliary duct.
Hanada K; Itoh M; Fujii K; Tsuchida A; Ooishi H; Kajiyama G
Cancer; 1996 Feb; 77(3):452-8. PubMed ID: 8630951
[TBL] [Abstract][Full Text] [Related]
20. Demonstration of ras and p53 gene mutations in carcinomas in the forestomach and intestine and soft tissue sarcomas induced by N-methyl-N-nitrosourea in the rat.
Matsumoto K; Iwase T; Hirono I; Nishida Y; Iwahori Y; Hori T; Asamoto M; Takasuka N; Kim DJ; Ushijima T; Nagao M; Tsuda H
Jpn J Cancer Res; 1997 Feb; 88(2):129-36. PubMed ID: 9119740
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
